Crison J - Search Results

1

Transmembrane transport of peptide type compounds: prospects for oral delivery.

Lipka E, Crison J, Amidon GL. Lipka E, et al. Among authors: crison j. J Control Release. 1996 May;39(2-3):121-9. doi: 10.1016/0168-3659(95)00145-x. J Control Release. 1996. PMID: 11539926 Review.

2

Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

Yu LX, Lipka E, Crison JR, Amidon GL. Yu LX, et al. Among authors: crison jr. Adv Drug Deliv Rev. 1996 Jun 12;19(3):359-76. doi: 10.1016/0169-409x(96)00009-9. Adv Drug Deliv Rev. 1996. PMID: 11540095 Review.

3

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Amidon GL, Lennernäs H, Shah VP, Crison JR. Amidon GL, et al. Among authors: crison jr. Pharm Res. 1995 Mar;12(3):413-20. doi: 10.1023/a:1016212804288. Pharm Res. 1995. PMID: 7617530 Free article.

4

Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine.

Crison JR, Shah VP, Skelly JP, Amidon GL. Crison JR, et al. J Pharm Sci. 1996 Sep;85(9):1005-11. doi: 10.1021/js930336p. J Pharm Sci. 1996. PMID: 8877894

5

Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.

Crison JR, Weiner ND, Amidon GL. Crison JR, et al. J Pharm Sci. 1997 Mar;86(3):384-8. doi: 10.1021/js960105t. J Pharm Sci. 1997. PMID: 9050810 Free article.

6

Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.

Jinno J, Oh Dm, Crison JR, Amidon GL. Jinno J, et al. Among authors: crison jr. J Pharm Sci. 2000 Feb;89(2):268-74. doi: 10.1002/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F. J Pharm Sci. 2000. PMID: 10688756 Free article.

7

Novel approach to the analysis of in vitro-in vivo relationships.

Polli JE, Crison JR, Amidon GL. Polli JE, et al. Among authors: crison jr. J Pharm Sci. 1996 Jul;85(7):753-60. doi: 10.1021/js9503587. J Pharm Sci. 1996. PMID: 8819002

8

Permeability and clearance views of drug absorption: a commentary.

Lennernäs H, Crison JR, Amidon GL. Lennernäs H, et al. Among authors: crison jr. J Pharmacokinet Biopharm. 1995 Jun;23(3):333-43. doi: 10.1007/BF02354289. J Pharmacokinet Biopharm. 1995. PMID: 8834200 Free article. No abstract available.

9

The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.

Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, Martinez MN, Lennernäs H, Wigal TL, Swinney DC, Polli JE, Serajuddin ATM, Cook JA, Dressman JB. Selen A, et al. Among authors: crison jr. J Pharm Sci. 2014 Nov;103(11):3377-3397. doi: 10.1002/jps.24162. Epub 2014 Sep 24. J Pharm Sci. 2014. PMID: 25256402 Review.

10

Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid.

Dickinson PA, Kesisoglou F, Flanagan T, Martinez MN, Mistry HB, Crison JR, Polli JE, Cruañes MT, Serajuddin ATM, Müllertz A, Cook JA, Selen A. Dickinson PA, et al. Among authors: crison jr. J Pharm Sci. 2016 Nov;105(11):3243-3255. doi: 10.1016/j.xphs.2016.07.024. Epub 2016 Sep 19. J Pharm Sci. 2016. PMID: 27659159 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters